The broader market is undergoing a significant reshuffle as we move through the second half of 2026. I'm told that institutional investors and family offices are increasingly looking past the usual tech giants, rotating capital into overlooked mid-caps, leveraged sector ETFs, and niche infrastructure players. This is one of the most notable strategy shifts we've seen this year.

DigitalOcean (DOCN.US)

DigitalOcean has been a major beneficiary of the ongoing AI boom, and its stock has rallied significantly in recent weeks. According to people familiar with the matter, internal optimism is high following a Q2 2026 report where revenue hit USD 281 million, up 29% year-over-year. The company is leaning heavily into AI inference growth, and I'm told we can expect further product rollouts before the next earnings cycle.

Webull (BULL.US)

The digital brokerage space is heating up. Webull recently saw a massive 90% year-over-year surge in customer assets, reaching USD 24 billion in Q1 2026. The stock jumped noticeably on news of narrowing losses. With the launch of robo-advised bond portfolios in July 2026, the company is aggressively expanding its wealth management footprint.

Booking Holdings (BKNG.US)

Despite macroeconomic jitters, travel demand remains incredibly resilient. Booking Holdings recently reported strong Q2 2026 revenue, outpacing broader consumer discretionary trends. I'm told the company’s forward-looking booking metrics for the upcoming holiday season are already tracking ahead of expectations.

Avantis U.S. Small Cap Value ETF (AVUV.US)

As the market rotation accelerates, small caps are outperforming the S&P. AVUV shares have been trading near 52-week highs in mid-2026. A recovery in risk appetite is driving significant capital inflows into the fund, signaling a broader confidence in domestic value stocks.

Direxion Daily Gold Miners Index Bull 2x Shares (NUGT.US)

Gold mining ETFs have been on a wild ride. Following a sharp double-digit drop in June 2026 tied to a strong U.S. jobs report, NUGT rebounded aggressively in August as underlying gold and silver prices rallied. Volatility here is expected to remain high through the end of the year.

SELLAS Life Sciences Group (SLS.US)

In the biotech sector, SELLAS has managed to beat recent consensus estimates, posting a narrower-than-expected loss for Q2 2026. I'm told all eyes are now on the upcoming Q4 2026 topline data for their SLS009 study in acute myeloid leukemia. Notably, Vanguard has accumulated a massive position of over 9.6 million shares.

Also

• Murata Manufacturing (MRAAY.US): Following a June 2026 collaboration with Synopsys on electromagnetic analysis tools, short interest in the tech giant has plunged by over 40%.
• STI (STI.US): I'm told that security and control panel businesses in this segment are navigating complex supply chain adjustments heading into the fall.
• SERV (SERV.US): Service sector equities are awaiting clearer consumer spending signals before making their next major directional move later this year.
• VELO (VELO.US): Consumer retail dynamics continue to shift, with niche consumer brands recalibrating their Q3 2026 distribution strategies.

This article does not constitute investment advice.